Zhou Yang, Irwin Melinda L, Ferrucci Leah M, McCorkle Ruth, Ercolano Elizabeth A, Li Fangyong, Stein Kevin, Cartmel Brenda
Yale Cancer Center, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States.
Yale Cancer Center, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States.
Gynecol Oncol. 2016 Jun;141(3):543-549. doi: 10.1016/j.ygyno.2016.04.006. Epub 2016 Apr 19.
There are limited data on outcomes and predictors of health-related quality of life (HRQOL) of ovarian cancer survivors. Therefore, we examined the trajectory and predictors of HRQOL one- and two-years post-diagnosis in this population.
365 ovarian cancer survivors, a subset of participants in the longitudinal American Cancer Society's Study of Cancer Survivors-I, completed questionnaires at one-year post-diagnosis on sociodemographics, clinical factors, and HRQOL (SF-36). 284 women had HRQOL data at two-years post-diagnosis. In this secondary data analysis, we examined HRQOL at both time points, changes in HRQOL and predictors of HRQOL with univariate and multivariate linear regression.
Mean mental and physical HRQOL scores one-year post-diagnosis were 49.37 (SD±11.59) and 45.96 (SD±10.89), respectively. Older age, lower income, higher disease stage, more comorbidities and greater symptom burden were associated with poorer physical functioning one year post-diagnosis. Younger age, higher stage, having an existing mental health issue, greater symptom burden, and not receiving chemotherapy were associated with poorer mental functioning. Disease recurrence between one- and two-years post-diagnosis and greater symptom burden were predictors of declining physical functioning from one- to two-years post-diagnosis. Mental functioning did not change significantly between assessments.
Overall mental and physical functioning of these ovarian cancer survivors was similar to the general population. However, lower HRQOL was associated with a number of variables, including disease recurrence, treatment status, symptom burden, age, and number of comorbidities. These findings can help health care providers identify survivors who may benefit from relevant interventions.
关于卵巢癌幸存者健康相关生活质量(HRQOL)的结局和预测因素的数据有限。因此,我们研究了该人群诊断后1年和2年时HRQOL的轨迹及预测因素。
365名卵巢癌幸存者,是美国癌症协会纵向癌症幸存者研究-I参与者的一个子集,在诊断后1年完成了关于社会人口统计学、临床因素和HRQOL(SF-36)的问卷调查。284名女性在诊断后2年有HRQOL数据。在这项二次数据分析中,我们通过单变量和多变量线性回归研究了两个时间点的HRQOL、HRQOL的变化以及HRQOL的预测因素。
诊断后1年时,心理和身体HRQOL的平均得分分别为49.37(标准差±11.59)和45.96(标准差±10.89)。年龄较大、收入较低、疾病分期较高、合并症较多以及症状负担较重与诊断后1年时较差的身体功能相关。年龄较小、分期较高、存在心理健康问题、症状负担较重以及未接受化疗与较差的心理功能相关。诊断后1年至2年期间疾病复发以及症状负担较重是诊断后1年至2年身体功能下降的预测因素。两次评估之间心理功能没有显著变化。
这些卵巢癌幸存者的总体心理和身体功能与一般人群相似。然而,较低的HRQOL与一些变量相关,包括疾病复发、治疗状态、症状负担、年龄和合并症数量。这些发现可以帮助医疗保健提供者识别可能从相关干预中受益的幸存者。